qiaole
@qiaole
On May 20th, Baiyang Pharmaceutical announced its plan to acquire 60.199% equity of Shanghai Baiyang Pharmaceutical Co., Ltd. (hereinafter referred to as "Baiyang Pharmaceutical") in cash for a total transaction price of 880 million yuan.
0 reply
0 recast
0 reaction